We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Generation of Standard Laboratory Values for Pneumococci Antibodies

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00567632
First Posted: December 5, 2007
Last Update Posted: January 17, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Johann Wolfgang Goethe University Hospital
December 4, 2007
December 5, 2007
January 17, 2011
October 2006
October 2010   (Final data collection date for primary outcome measure)
sufficient samples to calculate reference values [ Time Frame: 10(2006-10/2007) ]
sufficient samples to calculate reference values [ Time Frame: 10(2006-10/2007 ]
Complete list of historical versions of study NCT00567632 on ClinicalTrials.gov Archive Site
sufficient samples to correlate with screening assay [ Time Frame: 10/2006-10/2007 ]
Same as current
Not Provided
Not Provided
 
Generation of Standard Laboratory Values for Pneumococci Antibodies
Generation of Standard Laboratory Values for Pneumococci Antibodies
The determination of reference values is a necessary basis for research and clinical routine testing for pneumococci antibodies
This study is meant to determine specific pneumococcal antibodies stratified for age. The investigators also correlate our assay with the results from a commercially available pneumococcal screening ELISA (iGG1 and IgG2) in order to facilitate a screening for immunodeficiency, and to monitor the success of a performed immunization
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
human serum
Non-Probability Sample
any clinically and immunologically healthy subject of any age undergoing selective surgery
Reference Values
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
500
December 2010
October 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects undergoing elective surgery

Exclusion Criteria:

  • Chronic illness condition,
  • Immunodeficiency
Sexes Eligible for Study: All
Child, Adult, Senior
Yes
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT00567632
1-Rose
Yes
Not Provided
Not Provided
Markus A. Rose, ass. Professor of Paediatrics, Goethe University, Childrens' Hospital
Johann Wolfgang Goethe University Hospital
Not Provided
Study Chair: Markus A Rose, M.D., Ph.D., M.P.H Goethe University, childrens Hospital
Johann Wolfgang Goethe University Hospital
October 2007